Premature infants are at high risk of developing life-threatening lung infections, partly because their lungs are underdeveloped at birth. A new study from Washington University School of Medicine in St. Louis has found, in mice, that an inhaled drug promotes the development of lung immunity and reduces the risk of pneumonia.
Nearly all babies born prematurely receive antibiotics. A new study from Washington University School of Medicine in St. Louis suggests that such early antibiotic treatment could have long-lasting and potentially harmful effects on the gut microbiome.
Barbara B. Warner, MD, has been named director of the Division of Newborn Medicine at Washington University School of Medicine in St. Louis. Warner is known nationally for studies on the role of the gut microbiome in infant health and disease.